Financials
- Market Capitalization 2.48 B
- Employee 890
- Founded 1996
- CEO Matthew M. Mannelly
- Website www.prestigebrands.com
- Headquarter New York, United States
- FIGI BBG000QM0RZ4
- Industry 药品制造—专业与仿制药
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
15.16
市销率
2.79
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 1795 | RGC Regencell Bioscience Holdings Limited - Ordinary Shares | 5.50 USD | -0.36% | +3.77% | -6.78% | -60.46% | 2.72 B USD | ||
| 1841 | SUPN Supernus Pharmaceuticals, Inc. - Common Stock | 43.73 USD | -1.04% | -4.62% | -3.23% | -19.02% | 2.54 B USD | ||
| 1888 | BHC Bausch Health Companies Inc. Common Stock | 6.32 USD | +0.32% | -2.32% | +5.33% | -14.01% | 2.36 B USD | ||
| 1955 | HCM HUTCHMED (China) Limited - American Depositary Shares | 12.38 USD | -0.32% | -1.59% | +12.55% | -17.96% | 2.16 B USD |